1277 Results for: "MEDCHEMEXPRESS"
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
ROCAGLAMIDE (ROCAGLAMIDE A) A NATURALLY OCCURRING PRODUCT ISOLATED FROM THE GENUS AGLAIA, WITH THE IC50 OF ~50 NM FOR THE HEAT SHOCK REPORTER.IC50 VALUE: 50 NM (FOR THE HEAT SHOCK REP 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
ROCAGLAMIDE (ROCAGLAMIDE A) A NATURALLY OCCURRING PRODUCT ISOLATED FROM THE GENUS AGLAIA, WITH THE IC50 OF ~50 NM FOR THE HEAT SHOCK REPORTER.IC50 VALUE: 50 NM (FOR THE HEAT SHOCK REP 1 * 10 mg
Expand 1 Items
SOLUBILITY: SOLUBLE IN DMSO
SBI-0640756(SBI-756) IS A FIRST-IN-CLASS INHIBITOR THAT TARGETS EIF4G1 AND DISRUPTS THE EIF4F COMPLEX . SBI-756 ALSO SUPPRESSED AKT AND NF-ΚB SIGNALING.1) SBI-756 INHIBITED THE GROWTH OF NRAS, BRAF, AND NF1-MUTANT MELAN 1 * 25 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: SOLUBLE IN DMSO
SBI-0640756(SBI-756) IS A FIRST-IN-CLASS INHIBITOR THAT TARGETS EIF4G1 AND DISRUPTS THE EIF4F COMPLEX . SBI-756 ALSO SUPPRESSED AKT AND NF-ΚB SIGNALING.1) SBI-756 INHIBITED THE GROWTH OF NRAS, BRAF, AND NF1-MUTANT MELAN 1 * 25 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
THS-044 BINDING STABILIZES THE HIF2Α PAS-B FOLDED STATE, FOR REGUL ATING HIF2 ACTIVITY IN ENDOGENOUS AND CLINICAL SETTINGS.TARGET: HIF2ΑLIMITED TRYPSIN PROTEOLYSIS REVEALS THAT BOTH AP 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
THS-044 BINDING STABILIZES THE HIF2Α PAS-B FOLDED STATE, FOR REGUL ATING HIF2 ACTIVITY IN ENDOGENOUS AND CLINICAL SETTINGS.TARGET: HIF2ΑLIMITED TRYPSIN PROTEOLYSIS REVEALS THAT BOTH AP 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 120 MG/ML WATER <1 MG/ML
ZAFIRLUKAST IS A LEUKOTRIENE RECEPTOR ANTAGONIST (LTRA). (IC50=0.6 UM, IC50=7.0 UM FOR CYP2C9)TARGET: LEUKOTRIENE RECEPTORZAFIRLUKAST IS AN ORAL LEUKOTRIENE RECEPTOR A 1 * 500 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 120 MG/ML WATER <1 MG/ML
ZAFIRLUKAST IS A LEUKOTRIENE RECEPTOR ANTAGONIST (LTRA). (IC50=0.6 UM, IC50=7.0 UM FOR CYP2C9)TARGET: LEUKOTRIENE RECEPTORZAFIRLUKAST IS AN ORAL LEUKOTRIENE RECEPTOR A 1 * 500 mg
Expand 1 Items
Bioymifi (Synonyms: DR5 Activator) 10mg 1 * 10 mg
Supplier: MEDCHEMEXPRESS
Bioymifi (Synonyms: DR5 Activator) 10mg 1 * 10 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥9MG/ML WATER <1.2MG/ML ETHANOL ≥60MG/ML
GSK461364 IS A POTENT SMALL MOLECU LE POLO-LIKE KINASE 1 (PLK1) INHIBITOR WITH A KI OF 2.2 NM. IC50 VALUE: 2.2 NM(KI)TARGET: PLK1IN VITRO: GSK461364 IS 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥9MG/ML WATER <1.2MG/ML ETHANOL ≥60MG/ML
GSK461364 IS A POTENT SMALL MOLECU LE POLO-LIKE KINASE 1 (PLK1) INHIBITOR WITH A KI OF 2.2 NM. IC50 VALUE: 2.2 NM(KI)TARGET: PLK1IN VITRO: GSK461364 IS 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: 15 MG/ML
T-863(DGAT-1 INHIBITOR) IS AN ORALLY ACTIVE, SELECTIVE AND POTENT DGAT1 (ACYL-COA:DIACYLGLYCEROL ACYLTRANSFERASE 1) INHIBITOR THAT INTERACTS WITH THE ACYL-COA BINDING SITE OF DGAT1, I 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO: 15 MG/ML
T-863(DGAT-1 INHIBITOR) IS AN ORALLY ACTIVE, SELECTIVE AND POTENT DGAT1 (ACYL-COA:DIACYLGLYCEROL ACYLTRANSFERASE 1) INHIBITOR THAT INTERACTS WITH THE ACYL-COA BINDING SITE OF DGAT1, I 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 8 MG/ML (19 MM) WATER <1 MG/ML (<1 MM)
LOVASTATIN IS AN INHIBITOR OF HMG-C OA REDUCTASE WITH IC50 OF 3.4 NM, USED FOR LOWERING CHOLESTEROL (HYPOLIPIDEMIC AGENT). TARGET: HMG-COA REDUCTASELOVAS 1 * 50 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 8 MG/ML (19 MM) WATER <1 MG/ML (<1 MM)
LOVASTATIN IS AN INHIBITOR OF HMG-C OA REDUCTASE WITH IC50 OF 3.4 NM, USED FOR LOWERING CHOLESTEROL (HYPOLIPIDEMIC AGENT). TARGET: HMG-COA REDUCTASELOVAS 1 * 50 mg
Expand 1 Items
DABIGATRAN ETEXILATE (MESYLATE)
Supplier: MEDCHEMEXPRESS
DABIGATRAN ETEXILATE (MESYLATE)
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
ML216(CID-49852229) IS A POTENT INHIBITOR OF THE DNA UNWINDING ACT IVITY OF BLM HELICASE SHOWING SIMILAR IC50S OF 3.0 AND 0.97 ΜM FOR FULL LENGTH BLM AND BLM636–1298 RESPECTIVELY.IC50 1 * 50 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
ML216(CID-49852229) IS A POTENT INHIBITOR OF THE DNA UNWINDING ACT IVITY OF BLM HELICASE SHOWING SIMILAR IC50S OF 3.0 AND 0.97 ΜM FOR FULL LENGTH BLM AND BLM636–1298 RESPECTIVELY.IC50 1 * 50 mg
Expand 1 Items
SOLUBILITY: DMSO 95 MG/ML WATER 95 MG/ML ETHANOL <1 MG/ML
RIGOSERTIB (ON-01910) IS A NON-ATP-COMPETITIVE INHIBITOR OF PLK1 WITH IC50 OF 9 NM SHOWS 30-FOLD GREATER SELECTIVITY AGAINST PLK2 AND NO ACTIVITY TO PLK3.IC50 VALUE: 9 NM [1] TARGET: PL 1 * 5 mg
Supplier: MEDCHEMEXPRESS
SOLUBILITY: DMSO 95 MG/ML WATER 95 MG/ML ETHANOL <1 MG/ML
RIGOSERTIB (ON-01910) IS A NON-ATP-COMPETITIVE INHIBITOR OF PLK1 WITH IC50 OF 9 NM SHOWS 30-FOLD GREATER SELECTIVITY AGAINST PLK2 AND NO ACTIVITY TO PLK3.IC50 VALUE: 9 NM [1] TARGET: PL 1 * 5 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN WATER
SOLUBILITY: H2O: 10 MG/ML
EXENDIN-4(EXENATIDE), A 39 AMINO ACID PEPTIDE, ACTIVATES GLP-1 (G LUCAGON-LIKE PEPTIDE-1) RECEPTORS TO INCREASE INTRACELLULAR CAMP IN PANCREATIC ACINAR CELLS AND HAS NO EFFECT ON VIP 1 * 5 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN WATER
SOLUBILITY: H2O: 10 MG/ML
EXENDIN-4(EXENATIDE), A 39 AMINO ACID PEPTIDE, ACTIVATES GLP-1 (G LUCAGON-LIKE PEPTIDE-1) RECEPTORS TO INCREASE INTRACELLULAR CAMP IN PANCREATIC ACINAR CELLS AND HAS NO EFFECT ON VIP 1 * 5 mg